Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Colorectal Neoplasms

Free Subscription 01.09.2025 3 Ann Surg Oncol 6 Anticancer Res 1 BMC Cancer 1 Br J Cancer 2 Cancer Res 1 Eur J Cancer 1 Eur J Surg Oncol 1 Int J Colorectal Dis 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg Oncol

1. NAKAMICHI N, Shiozaki A, Shimizu H, Otsuji E, et al
   ASO Author Reflections: The Function and Clinical Significance of TRPV2 in Human Colon Cancer.
   Ann Surg Oncol. 2025 Aug 29. doi: 10.1245/s10434-025-18228.
   PubMed        
   
   
2. CHIU CC, Hsieh MC, Wang GL, Shi HY, et al
   Quality of Life and Minimal Clinically Important Difference in Colorectal Cancer Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy: A Large Prospective Cohort Study.
   Ann Surg Oncol. 2025 Aug 28. doi: 10.1245/s10434-025-18147.
   PubMed         Abstract available
   
   
3. HANSEN IS, Lappen KR, Brudvik KW, Rosok BI, et al
   A Randomized Controlled Trial of Resection Versus Thermal Ablation of Colorectal Cancer Liver Metastases (New Comet): Study Protocol.
   Ann Surg Oncol. 2025 Aug 26. doi: 10.1245/s10434-025-17984.
   PubMed         Abstract available
   
   

   
   Anticancer Res

4. WADA N, Nishida N, Takeda M, Sekido Y, et al
   Efficacy and Safety of S-1 and Oxaliplatin With Radiotherapy for Anorectal Cancer.
   Anticancer Res. 2025;45:3847-3857.
   PubMed         Abstract available
   
   
5. OTANI K, Kazama K, Aoyama T, Hashimoto I, et al
   Geriatric Nutritional Risk Index Predicts Prognosis in Older Patients With Colorectal Cancer: A Multicenter Study.
   Anticancer Res. 2025;45:4015-4025.
   PubMed         Abstract available
   
   
6. KOKAINE L, Daneberga Z, Satcs M, Zvina D, et al
   The Prognostic Role of microRNAs 142-5p, 182-3p, and 99a-3p in Locally Advanced Rectal Cancer Patients.
   Anticancer Res. 2025;45:3895-3912.
   PubMed         Abstract available
   
   
7. KIM J, Han Q, Li S, Kang BM, et al
   Combinations of Salmonella typhimurium A1-R, Recombinant Methioninase, and Chloroquine, Each Targeting Fundamental Cancer Hallmarks, Are Selectively Effective on Colon Cancer Cells Compared to Normal Fibroblasts.
   Anticancer Res. 2025;45:3661-3668.
   PubMed         Abstract available
   
   
8. NOZAWA H, Kasuga SO, Murono K, Sasaki K, et al
   Effects of Neoadjuvant Treatments on Mesorectal Computed Tomography Values and Tumor Regression in Rectal Cancer.
   Anticancer Res. 2025;45:3921-3930.
   PubMed         Abstract available
   
   
9. KIMURA N, Hiraki M, Furukawa S, Ikuno H, et al
   Oncological Outcomes of Varying Resection Margin Lengths in Colon Cancer Surgery: A Retrospective Analysis.
   Anticancer Res. 2025;45:4005-4013.
   PubMed         Abstract available
   
   

   
   BMC Cancer

10. LI X, Zhou X, Chen Y, Liu W, et al
    Global, regional, and national burden of colorectal cancer among women of childbearing age from 1990 to 2021: a systematic analysis based on the global burden of disease study 2021.
    BMC Cancer. 2025;25:1389.
    PubMed         Abstract available
    
    

    
    Br J Cancer

11. BALLHAUSEN A, Morano F, Stahler A, Lonardi S, et al
    Primary tumor sidedness and negative hyperselection to modulate anti-EGFR-based maintenance strategies in patients with RAS wild-type metastatic colorectal cancer: individual patient data pooled analysis of two randomized clinical trials.
    Br J Cancer. 2025 Aug 28. doi: 10.1038/s41416-025-03164.
    PubMed         Abstract available
    
    

    
    Cancer Res

12. ZHOU HM, Liu Y, Shi F, Qiu HW, et al
    CLK2 Regulates the KEAP1/NRF2 and p53 Pathways to Suppress Ferroptosis in Colorectal Cancer.
    Cancer Res. 2025 Aug 29. doi: 10.1158/0008-5472.CAN-24-4949.
    PubMed         Abstract available
    
    
13. ZHENG Z, Yuan F, Li J, Zhu X, et al
    Gut Microbiota-Mediated Bile Acid Metabolism Regulates Colorectal Cancer Liver Metastasis by Altering Neutrophil Recruitment.
    Cancer Res. 2025 Aug 27. doi: 10.1158/0008-5472.CAN-24-4425.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

14. ANTONIOTTI C, Marmorino F, Rossini D, Schmoll HJ, et al
    FOLFOXIRI/bevacizumab versus doublets/bevacizumab as initial therapy of unresectable liver-only, right-sided and/or RAS or BRAF mutated metastatic colorectal cancer: An individual patient data-based pooled analysis of randomized trials.
    Eur J Cancer. 2025;228:115713.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

15. SABAJO CR, Michels CTJ, van der Hout A, van den Heuvel B, et al
    The financial impact of implementation of a prehabilitation program for colorectal cancer patients in the Netherlands: A budget impact analysis.
    Eur J Surg Oncol. 2025;51:110375.
    PubMed         Abstract available
    
    

    
    Int J Colorectal Dis

16. CAI Y, Xu G, Shao Y, Ma D, et al
    Neoadjuvant therapy for resectable colorectal cancer pulmonary oligometastases: a retrospective cohort study.
    Int J Colorectal Dis. 2025;40:191.
    PubMed         Abstract available
    
    

    
    PLoS One

17. CHEN N, Zang B, Chen Y
    Predicting one-year post-surgical recurrence in colorectal liver metastasis using CT radiomics and machine learning.
    PLoS One. 2025;20:e0330828.
    PubMed         Abstract available
    
    
18. TAKAMI T, Itatani Y, Yoshida Y, Hoshino N, et al
    Protocol for a study to evaluate the safety and efficacy of prophylactic negative pressure wound therapy after abdominal perineal resection (VACPAC study).
    PLoS One. 2025;20:e0331361.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.